(Q40108889)

17 September 2017

Improving recruitment to clinical trials for cancer in childhood (English)

1 reference

17 September 2017

Kathy Pritchard-Jones

series ordinal

1

object named as

Kathy Pritchard-Jones

1 reference

17 September 2017

2

Mary Dixon-Woods

1 reference

PubMed ID

18374293

17 September 2017

Maria Grazia Valsecchi

series ordinal

4

object named as

Maria Grazia Valsecchi

1 reference

17 September 2017

Marianne Naafs-Wilstra

series ordinal

3

1 reference

17 September 2017

1 April 2008

1 reference

Lancet Oncology Commission

17 September 2017

1 reference

17 September 2017

9

1 reference

17 September 2017

4

1 reference

17 September 2017

392-399

1 reference

Parents' accounts of obtaining a diagnosis of childhood cancer.

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Pediatric cancer research from past successes through collaboration to future transdisciplinary research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Cancer in children and adolescents in Europe: developments over 20 years and future challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Novel targets for therapy in paediatric oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Recruiting children into cancer trials--role of the United Kingdom Children's Cancer Study Group (UKCCSG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Between remission and cure: patients, practitioners and the transformation of leukaemia in the late twentieth century

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

The need for more efficient trial designs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

New designs for phase 2 clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Strategy for randomised clinical trials in rare cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Web-based international studies in limited populations of pediatric leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

The EU clinical trials directive: 3 years on

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Acknowledgment of uncertainty: a fundamental means to ensure scientific and ethical validity in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Responsible research involving children.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Impact of individual physicians on enrollment of patients into clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Comparison of the informed consent process for randomized clinical trials in pediatric and adult oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Practicalities and ethics of running clinical trials in paediatric oncology - the UK experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Clinicians' attitudes to clinical trials of cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Informed consent for pediatric leukemia research: clinician perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Interpreter accuracy and informed consent among Spanish-speaking families with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Improving informed consent: suggestions from parents of children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Communication of randomization in childhood leukemia trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Stability of parental understanding of random assignment in childhood leukemia trials: an empirical examination of informed consent.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Informed consent in the Childrens Cancer Group: results of preliminary research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Writing wrongs? An analysis of published discourses about the use of patient information leaflets.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Clinicians' attitudes to recruitment to randomised trials in cancer care: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970101-3

7 January 2021

10.1016/S1470-2045(08)70101-3

Identifiers

DOI

1 reference

17 September 2017

1 reference

PubMed ID

18374293